209 related articles for article (PubMed ID: 20800692)
61. Investigation of hydrogen sulfide gas as a treatment against P. falciparum, murine cerebral malaria, and the importance of thiolation state in the development of cerebral malaria.
DellaValle B; Staalsoe T; Kurtzhals JA; Hempel C
PLoS One; 2013; 8(3):e59271. PubMed ID: 23555646
[TBL] [Abstract][Full Text] [Related]
62. Integrin αDβ2 influences cerebral edema, leukocyte accumulation and neurologic outcomes in experimental severe malaria.
Azevedo-Quintanilha IG; Vieira-de-Abreu A; Ferreira AC; Reis PA; Silva TI; Nascimento DO; Campbell RA; Estato V; Weyrich AS; Bozza PT; Zimmerman GA; Castro-Faria-Neto HC
PLoS One; 2019; 14(12):e0224610. PubMed ID: 31869339
[TBL] [Abstract][Full Text] [Related]
63. Ameliorating the in vivo antimalarial efficacy of artemether using nanostructured lipid carriers.
Vanka R; Kuppusamy G; Praveen Kumar S; Baruah UK; Karri VVSR; Pandey V; Babu PP
J Microencapsul; 2018 Mar; 35(2):121-136. PubMed ID: 29448884
[TBL] [Abstract][Full Text] [Related]
64. [Protective effects of artesunate combination on experimental cerebral malaria and nerve injury].
Jiang XH; Chen LN; Li K; Guo Y; Zheng ZY; Yang T; Zheng XJ; Li YJ; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2018 Aug; 43(15):3051-3057. PubMed ID: 30200698
[TBL] [Abstract][Full Text] [Related]
65. Genetic analysis of cerebral malaria in the mouse model infected with Plasmodium berghei.
Torre S; Langlais D; Gros P
Mamm Genome; 2018 Aug; 29(7-8):488-506. PubMed ID: 29922917
[TBL] [Abstract][Full Text] [Related]
66. Slow and continuous delivery of a low dose of nimodipine improves survival and electrocardiogram parameters in rescue therapy of mice with experimental cerebral malaria.
Martins YC; Clemmer L; Orjuela-Sánchez P; Zanini GM; Ong PK; Frangos JA; Carvalho LJ
Malar J; 2013 Apr; 12():138. PubMed ID: 23617605
[TBL] [Abstract][Full Text] [Related]
67. Brain microvessel cross-presentation is a hallmark of experimental cerebral malaria.
Howland SW; Poh CM; Gun SY; Claser C; Malleret B; Shastri N; Ginhoux F; Grotenbreg GM; Rénia L
EMBO Mol Med; 2013 Jul; 5(7):984-99. PubMed ID: 23681698
[TBL] [Abstract][Full Text] [Related]
68. Aminoquinolines afford resistance to cerebral malaria in susceptible mice.
Srbljanović J; Bobić B; Štajner T; Uzelac A; Opsenica I; Terzić-Jovanović N; Bauman N; Šolaja BA; Djurković-Djaković O
J Glob Antimicrob Resist; 2020 Dec; 23():20-25. PubMed ID: 32810640
[TBL] [Abstract][Full Text] [Related]
69. Distinct placental malaria pathology caused by different Plasmodium berghei lines that fail to induce cerebral malaria in the C57BL/6 mouse.
Rodrigues-Duarte L; de Moraes LV; Barboza R; Marinho CR; Franke-Fayard B; Janse CJ; Penha-Gonçalves C
Malar J; 2012 Jul; 11():231. PubMed ID: 22799533
[TBL] [Abstract][Full Text] [Related]
70. Transdermal glyceryl trinitrate as an effective adjunctive treatment with artemether for late-stage experimental cerebral malaria.
Orjuela-Sánchez P; Ong PK; Zanini GM; Melchior B; Martins YC; Meays D; Frangos JA; Carvalho LJ
Antimicrob Agents Chemother; 2013 Nov; 57(11):5462-71. PubMed ID: 23979751
[TBL] [Abstract][Full Text] [Related]
71. Antiplasmodial efficacy of
Satish PVV; Kumari DS; Sunita K
J Vector Borne Dis; 2017; 54(3):215-225. PubMed ID: 29097636
[TBL] [Abstract][Full Text] [Related]
72. The murine cerebral malaria phenomenon.
White NJ; Turner GD; Medana IM; Dondorp AM; Day NP
Trends Parasitol; 2010 Jan; 26(1):11-5. PubMed ID: 19932638
[TBL] [Abstract][Full Text] [Related]
73. Coincident parasite and CD8 T cell sequestration is required for development of experimental cerebral malaria.
McQuillan JA; Mitchell AJ; Ho YF; Combes V; Ball HJ; Golenser J; Grau GE; Hunt NH
Int J Parasitol; 2011 Feb; 41(2):155-63. PubMed ID: 20828575
[TBL] [Abstract][Full Text] [Related]
74. IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites.
Niikura M; Kamiya S; Nakane A; Kita K; Kobayashi F
Int J Parasitol; 2010 Jan; 40(1):101-8. PubMed ID: 19735663
[TBL] [Abstract][Full Text] [Related]
75. Perillyl alcohol exhibits in vitro inhibitory activity against Plasmodium falciparum and protects against experimental cerebral malaria.
Rodriguez AAM; Carvalho LJM; Kimura EA; Katzin AM
Int J Antimicrob Agents; 2018 Mar; 51(3):370-377. PubMed ID: 28843818
[TBL] [Abstract][Full Text] [Related]
76. Cerebral malaria.
Postels DG; Birbeck GL
Handb Clin Neurol; 2013; 114():91-102. PubMed ID: 23829902
[TBL] [Abstract][Full Text] [Related]
77. Filaria-induced IL-10 suppresses murine cerebral malaria.
Specht S; Ruiz DF; Dubben B; Deininger S; Hoerauf A
Microbes Infect; 2010 Aug; 12(8-9):635-42. PubMed ID: 20420933
[TBL] [Abstract][Full Text] [Related]
78. Fas has a role in cerebral malaria, but not in proliferation or exclusion of the murine parasite in mice.
Ohno T; Kobayashi F; Nishimura M
Immunogenetics; 2005 May; 57(3-4):293-6. PubMed ID: 15900502
[TBL] [Abstract][Full Text] [Related]
79. Evaluation of herbal antimalarial MAMA decoction-amodiaquine combination in murine malaria model.
Adepiti AO; Elujoba AA; Bolaji OO
Pharm Biol; 2016 Oct; 54(10):2298-303. PubMed ID: 27057621
[TBL] [Abstract][Full Text] [Related]
80. Glucocorticosteroids in nano-sterically stabilized liposomes are efficacious for elimination of the acute symptoms of experimental cerebral malaria.
Waknine-Grinberg JH; Even-Chen S; Avichzer J; Turjeman K; Bentura-Marciano A; Haynes RK; Weiss L; Allon N; Ovadia H; Golenser J; Barenholz Y
PLoS One; 2013; 8(8):e72722. PubMed ID: 23991146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
